Aryl hydrocarbon receptor and intestinal immunity review-article

Mucosal Immunology

Volumn 11, Issue 4, 2018, Pages 1024-1038

  Lamas, Bruno ^a,b   Natividad, Jane M ^b   Sokol, Harry ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; INDOLE; LIGAND; MELATONIN; POLYCYCLIC AROMATIC HYDROCARBON; SEROTONIN; TRYPTOPHAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; POLYCHLORINATED DIBENZODIOXIN;

AMINO ACID METABOLISM; BINDING AFFINITY; BONE MARROW CELL; COLORECTAL CANCER; ENTERITIS; GENE EXPRESSION; GENETIC CONSERVATION; HUMAN; IMMUNOCOMPETENT CELL; INTESTINE EPITHELIUM CELL; INTESTINE INFECTION; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; INTRAEPITHELIAL LYMPHOCYTE; LIGAND BINDING; LYMPHOID CELL; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VEGETABLE; ANIMAL; HOMEOSTASIS; IMMUNOLOGY; INTESTINE; METABOLISM; PHYSIOLOGY;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; HOMEOSTASIS; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; INTESTINES; POLYCHLORINATED DIBENZODIOXINS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 85045029559     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/s41385-018-0019-2     Document Type: Review

References (210)

1. Gu, Y. Z., Hogenesch, J. B. & Bradfield, C. A. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519-561 (2000).
2. Mandal, P. K. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. B, Biochem. Syst. Environ. Physiol. 175, 221-230 (2005).
3. Frericks, M., Meissner, M. & Esser, C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol. Appl. Pharmacol. 220, 320-332 (2007).
4. Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250 (2010).
5. Hankinson, O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340 (1995).
6. Schmidt, J. V. & Bradfield, C. A. Ah receptor signaling pathways. Annu. Rev. Cell. Dev. Biol. 12, 55-89 (1996).
7. Denison, M. S. & Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334 (2003).
8. Denison, M. S. & Heath-Pagliuso, S. The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull. Environ. Contam. Toxicol. 61, 557-568 (1998).
9. Kazlauskas, A., Poellinger, L. & Pongratz, I. Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J. Biol. Chem. 274, 13519-13524 (1999).
10. Hord, N. G. & Perdew, G. H. Physicochemical and immunocytochemical analysis of the aryl hydrocarbon receptor nuclear translocator: characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator. Mol. Pharmacol. 46, 618-626 (1994).
11. Probst, M. R., Reisz-Porszasz, S., Agbunag, R. V., Ong, M. S. & Hankinson, O. Role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon (dioxin) receptor action. Mol. Pharmacol. 44, 511-518 (1993).
12. Roberts, B. J. & Whitelaw, M. L. Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway. J. Biol. Chem. 274, 36351-36356 (1999).
13. Friling, R. S., Bensimon, A., Tichauer, Y. & Daniel, V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA 87, 6258-6262 (1990).
14. Brauze, D. et al. Diversified expression of aryl hydrocarbon receptor dependent genes in human laryngeal squamous cell carcinoma cell lines treated with β-naphthoflavone. Toxicol. Lett. 231, 99-107 (2014).
15. Ma, Q., Kinneer, K., Bi, Y., Chan, J. Y. & Kan, Y. W. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem. J. 377, 205-213 (2004).
16. Auyeung, D. J., Kessler, F. K. & Ritter, J. K. Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway. Mol. Pharmacol. 63, 119-127 (2003).
17. Dunn, T. J., Lindahl, R. & Pitot, H. C. Differential gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Noncoordinate regulation of a TCDD-induced aldehyde dehydrogenase and cytochrome P-450c in the rat. J. Biol. Chem. 263, 10878-10886 (1988).
18. Stockinger, B., Meglio, P., Di, Gialitakis, M. & Duarte, J. H. H. The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32, 403-432 (2014).
19. Puga, A. et al. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem. 275, 2943-2950 (2000).
20. Frueh, F. W., Hayashibara, K. C., Brown, P. O. & Whitlock, J. P. Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol. Lett. 122, 189-203 (2001).
21. Boverhof, D. R. et al. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol. Sci. 85, 1048-1063 (2005).
22. Tijet, N. et al. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69, 140-153 (2006).
23. Puga, A., Ma, C. & Marlowe, J. L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 77, 713-722 (2009).
24. Vogel, C. F., Sciullo, E. & Matsumura, F. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochem. Biophys. Res. Commun. 363, 722-726 (2007).
25. Tian, Y. Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochem. Pharmacol. 77, 670-680 (2009).
26. Ohtake, F., Fujii-Kuriyama, Y. & Kato, S. AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem. Pharmacol. 77, 474-484 (2009).
27. Wilson, S. R., Joshi, A. D. & Elferink, C. J. The tumor suppressor Kruppel-like factor 6 is a novel aryl hydrocarbon receptor DNA binding partner. J. Pharmacol. Exp. Ther. 345, 419-429 (2013).
28. Dang, D. T., Pevsner, J. & Yang, V. W. The biology of the mammalian Krüppel-like family of transcription factors. Int. J. Biochem. Cell. Biol. 32, 1103-1121 (2000).
29. Andreoli, V., Gehrau, R. C. & Bocco, J. L. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death. IUBMB. Life. 62, 896-905 (2010).
30. Narla, G. et al. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma. Oncogene. 26, 4428-4434 (2007).
31. Sangodkar, J. et al. Functional role of the KLF6 tumour suppressor gene in gastric cancer. Eur. J. Cancer. 45, 666-676 (2009).
32. Reeves, H. L. et al. Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer. Gastroenterology. 126, 1090-1103 (2004).
33. Bureau, C. et al. Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis. Curr. Genomics. 10, 353-360 (2009).
34. Jackson, D. P., Li, H., Mitchell, K. A., Joshi, A. D. & Elferink, C. J. Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression. Mol. Pharmacol. 85, 533-541 (2014).
35. Gillner, M. et al. Interactions of indolo[3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol. 44, 336-345 (1993).
36. Kafafi, S. A., Afeefy, H. Y., Said, H. K. & Kafafi, A. G. Relationship between aryl hydrocarbon receptor binding, induction of aryl hydrocarbon hydroxylase and 7-ethoxyresorufin O-deethylase enzymes, and toxic activities of aromatic xenobiotics in animals. A new model. Chem. Res. Toxicol. 6, 328-334 (1993).
37. Denison, M. S., Phelan, D., Winter, G. M. & Ziccardi, M. H. Carbaryl, a carbamate insecticide, is a ligand for the hepatic Ah (dioxin) receptor. Toxicol. Appl. Pharmacol. 152, 406-414 (1998).
38. Poland, A. & Knutson, J. C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554 (1982).
39. Wattenberg, L. W. & Loub, W. D. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer. Res. 38, 1410-1413 (1978).
40. Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C. & Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 88, 9543-9547 (1991).
41. Loub, W. D., Wattenberg, L. W. & Davis, D. W. Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J. Natl. Cancer. Inst. 54, 985-988 (1975).
42. Shapiro, T. A., Fahey, J. W., Wade, K. L., Stephenson, K. K. & Talalay, P. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: metabolism and excretion in humans. Cancer. Epidemiol. Biomarkers. Prev. 10, 501-508 (2001).
43. Ito, S., Chen, C., Satoh, J., Yim, S. & Gonzalez, F. J. Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J. Clin. Invest. 117, 1940-1950 (2007).
44. Gillner, M., Bergman, J., Cambillau, C. & Gustafsson, J. A. Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis. 10, 651-654 (1989).
45. Gillner, M., Bergman, J., Cambillau, C., Fernström, B. & Gustafsson, J. A. Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol. 28, 357-363 (1985).
46. MacDonald, C. J., Ciolino, H. P. & Yeh, G. C. Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1. Cancer. Res. 61, 3919-3924 (2001).
47. Ciolino, H. P., Daschner, P. J., Wang, T. T. & Yeh, G. C. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol. 56, 197-206 (1998).
48. Ashida, H. Suppressive effects of flavonoids on dioxin toxicity. Biofactors. 12, 201-206 (2000).
49. Yannai, S., Day, A. J., Williamson, G. & Rhodes, M. J. Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines. Food. Chem. Toxicol. 36, 623-630 (1998).
50. Ashida, H., Fukuda, I., Yamashita, T. & Kanazawa, K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 476, 213-217 (2000).
51. Ciolino, H. P., Wang, T. T. & Yeh, G. C. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer. Res. 58, 2754-2760 (1998).
52. Canivenc-Lavier, M. C. et al. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. Toxicology. 114, 19-27 (1996).
53. Amakura, Y. et al. Preliminary screening of the inhibitory effect of food extracts on activation of the aryl hydrocarbon receptor induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biol. Pharm. Bull. 25, 272-274 (2002).
54. Paganga, G. & Rice-Evans, C. A. The identification of flavonoids as glycosides in human plasma. FEBS Lett. 401, 78-82 (1997).
55. Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C. & Bradfield, C. A. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93, 6731-6736 (1996).
56. Lahvis, G. P. et al. Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci USA 97, 10442-10447 (2000).
57. Perdew, G. H. & Babbs, C. F. Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol. Nutr. Cancer. 16, 209-218 (1991).
58. Bradfield, C. A. & Bjeldanes, L. F. Modification of carcinogen metabolism by indolylic autolysis products of Brassica oleraceae. Adv. Exp. Med. Biol. 289, 153-163 (1991).
59. Kruif, C. A. De et al. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem. Biol. Interact. 80, 303-315 (1991).
60. Jellinck, P. H. et al. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem. Pharmacol. 45, 1129-1136 (1993).
61. Paine, A. J. & Francis, J. E. The induction of benzo[a]pyrene-3-mono-oxygenase by singlet oxygen in liver cell culture is mediated by oxidation products of histidine. Chem. Biol. Interact. 30, 343-353 (1980).
62. Paine, A. J. Induction of benzo[a]pyrene Mono-oxygenase in liver cell culture by the photochemical generation of active oxygen species. Evidence for the involvement of singlet oxygen and the formation of a stable inducing intermediate. Biochem. J. 158, 109-117 (1976).
63. Goerz, G., Merk, H., Bolsen, K., Tsambaos, D. & Berger, H. Influence of chronic UV-light exposure on hepatic and cutaneous monooxygenases. Experientia. 39, 385-386 (1983).
64. Goerz, G. et al. Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes. Arch. Dermatol. Res. 289, 46-51 (1996).
65. Rannug, U. et al. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem. Biol. 2, 841-845 (1995).
66. Rannug, A. et al. Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J. Biol. Chem. 262, 15422-15427 (1987).
67. Rannug, A. & Fritsche, E. The aryl hydrocarbon receptor and light. Biol. Chem. 387, 1149-1157 (2006).
68. Yanofsky, C., Horn, V. & Gollnick, P. Physiological studies of tryptophan transport and tryptophanase operon induction in Escherichia coli. J. Bacteriol. 173, 6009-6017 (1991).
69. Fujioka, M. & Wada, H. The bacterial oxidation of indole. Biochim. Biophys. Acta. 158, 70-78 (1968).
70. Berry, D. F., Madsen, E. L. & Bollag, J. M. Conversion of indole to oxindole under methanogenic conditions. Appl. Environ. Microbiol. 53, 180-182 (1987).
71. Zelante, T., Rossana et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 39, 372-385 (2013).
72. Cervantes-Barragan, L. et al. Lactobacillus reuteri induces gut intraepithelial CD4 + CD8αα + T cells. Science 357, 806-810 (2017).
73. Kawamura-Sato, K. et al. Role of multiple efflux pumps in Escherichia coli in indole expulsion. FEMS. Microbiol. Lett. 179, 345-352 (1999).
74. Piñero-Fernandez, S., Chimerel, C., Keyser, U. F. & Summers, D. K. Indole transport across Escherichia coli membranes. J. Bacteriol. 193, 1793-1798 (2011).
75. Bansal, T., Alaniz, R. C., Wood, T. K. & Jayaraman, A. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc Natl Acad Sci USA 107, 228-233 (2010).
76. Whitfield-Cargile, C. M. et al. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy. Gut Microbes 7, 246-261 (2016).
77. Fung, T. C., Olson, C. A. & Hsiao, E. Y. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 20, 145-155 (2017).
78. Mezrich, J. D. et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185, 3190-3198 (2010).
79. Bohár, Z., Toldi, J., Fülöp, F. & Vécsei, L. Changing the face of kynurenines and neurotoxicity: therapeutic considerations. Int. J. Mol. Sci. 16, 9772-9793 (2015).
80. Han, Q., Robinson, H., Cai, T., Tagle, D. A. & Li, J. Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol. Cell. Biol. 29, 784-793 (2009).
81. DiNatale, B. C. et al. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol. Sci. 115, 89-97 (2010).
82. Goasduff, T., Dréano, Y., Guillois, B., Ménez, J. F. & Berthou, F. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem. Pharmacol. 52, 1915-1919 (1996).
83. Iba, M. M., Scholl, H., Fung, J., Thomas, P. E. & Alam, J. Induction of pulmonary CYP1A1 by nicotine. Xenobiotica. 28, 827-843 (1998).
84. Kim, H., Reddy, S. & Novak, R. F. 3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue. Drug. Metab. Dispos. 23, 818-824 (1995).
85. Daujat, M. et al. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochem. Biophys. Res. Commun. 188, 820-825 (1992).
86. Aix, L., Rey-Grobellet, X., Larrieu, G., Lesca, P. & Galtier, P. Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochem. Biophys. Res. Commun. 202, 1483-1489 (1994).
87. Daujat, M. et al. Induction of CYP1A1 gene by benzimidazole derivatives during Caco-2 cell differentiation. Evidence for an aryl-hydrocarbon receptor-mediated mechanism. Eur. J. Biochem. 237, 642-652 (1996).
88. Jeong, H. G., Lee, S. S., Kim, H. K. & Yang, K. H. Murine Cyp1a-1 induction in mouse hepatoma Hepa-1C1C7 cells by myristicin. Biochem. Biophys. Res. Commun. 233, 619-622 (1997).
89. Marcus, C. B., Wilson, N. M., Jefcoate, C. R., Wilkinson, C. F. & Omiecinski, C. J. Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methylenedioxybenzenes. Arch. Biochem. Biophys. 277, 8-16 (1990).
90. Delescluse, C. et al. Cytotoxic effects and induction of cytochromes P450 1A1/2 by insecticides, in hepatic or epidermal cells: binding capability to the Ah receptor. Toxicol. Lett. 96-97, 33-39 (1998).
91. Ledirac, N. et al. Carbaryl induces CYP1A1 gene expression in HepG2 and HaCaT cells but is not a ligand of the human hepatic Ah receptor. Toxicol. Appl. Pharmacol. 144, 177-182 (1997).
92. Sandoz, C., Lesca, P., Narbonne, J. F. & Carpy, A. Molecular characteristics of carbaryl, a CYP1A1 gene inducer. Arch. Biochem. Biophys. 373, 275-280 (2000).
93. Hahn, M. E. Aryl hydrocarbon receptors: diversity and evolution. Chem. Biol. Interact. 141, 131-160 (2002).
94. Hahn, M. E. The aryl hydrocarbon receptor: a comparative perspective. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol. 121, 23-53 (1998).
95. Hahn, M. E., Karchner, S. I., Shapiro, M. A. & Perera, S. A. Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family. Proc Natl Acad Sci USA 94, 13743-13748 (1997).
96. Ramadoss, P. & Perdew, G. H. Use of 2-azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a probe to determine the relative ligand affinity of human versus mouse aryl hydrocarbon receptor in cultured cells. Mol. Pharmacol. 66, 129-136 (2004).
97. Murray, I. A., Patterson, A. D. & Perdew, G. H. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat. Rev. Cancer. 14, 801-814 (2014).
98. Flaveny, C. A., Murray, I. A. & Perdew, G. H. Differential gene regulation by the human and mouse aryl hydrocarbon receptor. Toxicol. Sci. 114, 217-225 (2010).
99. Leavy, O. Mucosal immunology: the 'AHR diet' for mucosal homeostasis. Nat. Rev. Immunol. 11, 806 (2011).
100. Furue, M., Takahara, M., Nakahara, T. & Uchi, H. Role of AhR/ARNT system in skin homeostasis. Arch. Dermatol. Res. 306, 769-779 (2014).
101. Hao, N. & Whitelaw, M. L. The emerging roles of AhR in physiology and immunity. Biochem. Pharmacol. 86, 561-570 (2013).
102. Han, B. et al. Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway. Shock. 46, 319-328 (2016).
103. Chinen, I. et al. The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis. Int. Immunol. 27, 405-415 (2015).
104. Sonnenberg, G. F., Fouser, L. A. & Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12, 383-390 (2011).
105. Stelter, C. et al. Salmonella-induced mucosal lectin RegIIIβ kills competing gut microbiota. PLoS. ONE. 6, e20749 (2011).
106. Schiering, C. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 542, 242-245 (2017).
107. Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561-1565 (2011).
108. Chimerel, C. et al. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep 9, 1202-1208 (2014).
109. Chiba, T., Chihara, J. & Furue, M. Role of the Arylhydrocarbon Receptor (AhR) in the Pathology of Asthma and COPD. J Allergy (Cairo) 2012, 372384 (2012).
110. Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629-640 (2011).
111. Stockinger, B. & Omenetti, S. The dichotomous nature of T helper 17 cells. Nat. Rev. Immunol. 17, 535-544 (2017).
112. Qiu, J. et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity. 39, 386-399 (2013).
113. Kimura, A. et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 206, 2027-2035 (2009).
114. Nguyen, N. T. et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA 107, 19961-19966 (2010).
115. Quintana, F. J. et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 107, 20768-20773 (2010).
116. Zindl, C. L. et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci USA 110, 12768-12773 (2013).
117. Chen, F. et al. mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production. J. Immunol. 196, 4390-4399 (2016).
118. Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity. 36, 92-104 (2012).
119. Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237-241 (2014).
120. Rutz, S., Eidenschenk, C. & Ouyang, W. IL-22, not simply a Th17 cytokine. Immunol. Rev. 252, 116-132 (2013).
121. Rescigno, M. Intestinal dendritic cells. Adv. Immunol. 107, 109-138 (2010).
122. Schiavi, E., Smolinska, S. & O'Mahony, L. Intestinal dendritic cells. Curr. Opin. Gastroenterol. 31, 98-103 (2015).
123. Liu, H., Ramachandran, I. & Gabrilovich, D. I. Regulation of plasmacytoid dendritic cell development in mice by aryl hydrocarbon receptor. Immunol. Cell. Biol. 92, 200-203 (2014).
124. Goudot, C. et al. Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages. Immunity. 47, 582-596 (2017). e6.
125. Chng, S. H. et al. Ablating the aryl hydrocarbon receptor (AhR) in CD11c + cells perturbs intestinal epithelium development and intestinal immunity. Sci. Rep. 6, 23820 (2016).
126. Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13, 144-151 (2011).
127. Kinnebrew, M. A. et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity. 36, 276-287 (2012).
128. Rendon, J. L. et al. The role of aryl hydrocarbon receptor in interleukin-23-dependent restoration of interleukin-22 following ethanol exposure and burn injury. Ann. Surg. 259, 582-590 (2014).
129. Siegemund, S. et al. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis. Int. Immunol. 21, 555-565 (2009).
130. Muñoz, M. et al. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206, 3047-3059 (2009).
131. Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109 (2008).
132. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y. & Kishimoto, T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 105, 9721-9726 (2008).
133. Veldhoen, M., Hirota, K., Christensen, J., O'Garra, A. & Stockinger, B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206, 43-49 (2009).
134. Lee, Y. et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991-999 (2012).
135. Brandstätter, O. et al. Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor. Sci. Rep. 6, 26091 (2016).
136. Cui, G. et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 121, 658-670 (2011).
137. Rutz, S. et al. Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in T(H)17 cells. Nat. Immunol. 12, 1238-1245 (2011).
138. Yeste, A. et al. IL-21 induces IL-22 production in CD4 + T cells. Nat. Commun. 5, 3753 (2014).
139. Quintana, F. J. et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71 (2008).
140. Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
141. Elizondo, G., Rodríguez-Sosa, M., Estrada-Muñiz, E., Gonzalez, F. J. & Vega, L. Deletion of the aryl hydrocarbon receptor enhances the inflammatory response to Leishmania major infection. Int. J. Biol. Sci. 7, 1220-1229 (2011).
142. Goettel, J. A. et al. AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. Cell Rep 17, 1318-1329 (2016).
143. Gandhi, R. et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 11, 846-853 (2010).
144. Funatake, C. J. et al. Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response. J. Immunotoxicol. 6, 194-203 (2009).
145. Saraiva, M. & O'Garra, A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10, 170-181 (2010).
146. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861 (2010).
147. Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221-225 (2015).
148. Monteleone, I. et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology. 141, 237-248 (2011). 248.e1.
149. Long, X. et al. NK cells contribute to persistent airway inflammation and AHR during the later stage of RSV infection in mice. Med. Microbiol. Immunol. 205, 459-470 (2016).
150. Zhao, Y. et al. MicroRNA-124 Promotes Intestinal Inflammation by Targeting Aryl Hydrocarbon Receptor in Crohn's Disease. J. Crohns Colitis 10, 703-712 (2016).
151. Li, J., Doty, A. & Glover, S. C. Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patients. Inflamm Cell Signal 3, e1404 (2016).
152. Lamas, B. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598-605 (2016).
153. Furumatsu, K. et al. A role of the aryl hydrocarbon receptor in attenuation of colitis. Dig. Dis. Sci. 56, 2532-2544 (2011).
154. Takamura, T. et al. Activation of the aryl hydrocarbon receptor pathway may ameliorate dextran sodium sulfate-induced colitis in mice. Immunol. Cell. Biol. 88, 685-689 (2010).
155. Singh, N. P. et al. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS. ONE. 6, e23522 (2011).
156. Ivanov, S. & Lindén, A. Interleukin-17 as a drug target in human disease. Trends. Pharmacol. Sci. 30, 95-103 (2009).
157. Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 31, 677-689 (2009).
158. Kumar, P. et al. Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. Immunity. 44, 659-671 (2016).
159. Abildgaard, A., Elfving, B., Hokland, M., Wegener, G. & Lund, S. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology. 79, 40-48 (2017).
160. Fukumoto, S. et al. Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis. Immunol. Cell. Biol. 92, 460-465 (2014).
161. Daniel, H. et al. High-fat diet alters gut microbiota physiology in mice. ISME. J. 8, 295-308 (2014).
162. Lamas, B. et al. Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence. Gut (2017). https://doi.org/10.1136/gutjnl-2017-314195
163. Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477-481 (2012).
164. Shizuma, T., Mori, H. & Fukuyama, N. Protective effect of tryptophan against dextran sulfate sodium-induced experimental colitis. Turk. J. Gastroenterol. 24, 30-35 (2013).
165. Islam, J. et al. Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice. J. Nutr. Biochem. 42, 43-50 (2017).
166. Collins, J. W. et al. Citrobacter rodentium: infection, inflammation and the microbiota. Nat. Rev. Microbiol. 12, 612-623 (2014).
167. Guo, X. et al. Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. Immunity. 42, 731-743 (2015).
168. Sekine, H. et al. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol. Cell. Biol. 29, 6391-6400 (2009).
169. Masuda, K. et al. Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages. Int. Immunol. 23, 637-645 (2011).
170. Bessede, A. et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511, 184-190 (2014).
171. Kimura, A. et al. Aryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production. Int. Immunol. 26, 209-220 (2014).
172. Shi, L. Z. et al. The aryl hydrocarbon receptor is required for optimal resistance to Listeria monocytogenes infection in mice. J. Immunol. 179, 6952-6962 (2007).
173. Julliard, W. et al. Amelioration of Clostridium difficile Infection in Mice by Dietary Supplementation With Indole-3-carbinol. Ann. Surg. 265, 1183-1191 (2017).
174. Oh, S., Go, G. W., Mylonakis, E. & Kim, Y. The bacterial signalling molecule indole attenuates the virulence of the fungal pathogen Candida albicans. J. Appl. Microbiol. 113, 622-628 (2012).
175. Kawajiri, K. et al. Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+mice with natural ligands. Proc Natl Acad Sci USA 106, 13481-13486 (2009).
176. Ikuta, T. et al. ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice. Carcinogenesis. 34, 1620-1627 (2013).
177. Greten, F. R. et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130, 918-931 (2007).
178. Ikuta, T., Kurosumi, M., Yatsuoka, T. & Nishimura, Y. Tissue distribution of aryl hydrocarbon receptor in the intestine: Implication of putative roles in tumor suppression. Exp. Cell. Res. 343, 126-134 (2016).
179. Bonnesen, C., Eggleston, I. M. & Hayes, J. D. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer. Res. 61, 6120-6130 (2001).
180. Kim, Y. H. et al. 3,3'-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm. Bowel. Dis. 15, 1164-1173 (2009).
181. Richmond, O. et al. The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells. PLoS. ONE. 9, e95058 (2014).
182. Lin, P. et al. Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxicol. Pathol. 31, 22-30 (2003).
183. Zhao, S. et al. HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription. Cancer. Lett. 330, 41-48 (2013).
184. Koliopanos, A. et al. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene. 21, 6059-6070 (2002).
185. Ma, J.-X. X. et al. Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China. Cancer. Lett. 240, 253-260 (2006).
186. Androutsopoulos, V. P. et al. Expression profile of CYP1A1 and CYP1B1 enzymes in colon and bladder tumors. PLoS. ONE. 8, e82487 (2013).
187. Andersson, P. et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci USA 99, 9990-9995 (2002).
188. Xie, G., Peng, Z. & Raufman, J.-P. P. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation. Am. J. Physiol. Gastrointest. Liver. Physiol. 302, G1006-G1015 (2012).
189. Haarmann-Stemmann, T., Bothe, H. & Abel, J. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem. Pharmacol. 77, 508-520 (2009).
190. Gomez-Duran, A. et al. Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling. Biochem. Pharmacol. 77, 700-712 (2009).
191. Tompkins, L. M. et al. A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells. Biochem. Pharmacol. 80, 1754-1761 (2010).
192. Egeblad, M. & Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2, 161-174 (2002).
193. Noguchi, K., Katayama, K., Mitsuhashi, J. & Sugimoto, Y. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Adv. Drug. Deliv. Rev. 61, 26-33 (2009).
194. Roth, C. W., Hoch, J. A. & DeMoss, R. D. Physiological studies of biosynthetic indole excretion in Bacillus alvei. J. Bacteriol. 106, 97-106 (1971).
195. Brazier, J. S. et al. Isolation and identification of Clostridium spp. from infections associated with the injection of drugs: experiences of a microbiological investigation team. J. Med. Microbiol 51, 985-9 (2002).
196. Elsden, S. R., Hilton, M. G. & Waller, J. M. The end products of the metabolism of aromatic amino acids by Clostridia. Arch. Microbiol. 107, 283-8 (1976).
197. Voss, J. G. Differentiation of two groups of Corynebacterium acnes. J. Bacteriol. 101, 392-7 (1970).
198. Schleifer, K. H., Kilpper-Bälz, R., Kraus, J. & Gehring, F. Relatedness and classification of Streptococcus mutans and 'mutans-like' streptococci. J. Dent. Res. 63, 1047-50 (1984).
199. Tannock, G. W. Characteristics of Bacteroides isolates from the cecum of conventional mice. Appl. Environ. Microbiol. 33, 745-50 (1977).
200. DeMoss, R. D. & Moser, K. Tryptophanase in diverse bacterial species. J. Bacteriol. 98, 167-71 (1969).
201. Booth, E. V. & McDonald, S. A new group of enterobacteria, possibly a new Citrobacter sp. J. Med. Microbiol. 4, 329-36 (1971).
202. Li, G. & Young, K. D. Indole production by the tryptophanase TnaA in Escherichia coli is determined by the amount of exogenous tryptophan. Microbiology (Reading, Engl.) 159, 402-10 (2013).
203. Pickett, M. J. Methods for identification of flavobacteria. J. Clin. Microbiol. 27, 2309-15 (1989).
204. Langworth, B. F. Fusobacterium necrophorum: its characteristics and role as an animal pathogen. Bacteriol Rev 41, 373-90 (1977).
205. Kilian, M. A taxonomic study of the genus Haemophilus, with the proposal of a new species. J. Gen. Microbiol. 93, 9-62 (1976).
206. Liu, Y., Mee, B. J. & Mulgrave, L. Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases. J. Clin. Microbiol. 35, 2365-9 (1997).
207. Rezwan, F., Lan, R. & Reeves, P. R. Molecular basis of the indole-negative reaction in Shigella strains: extensive damages to the tna operon by insertion sequences. J. Bacteriol. 186, 7460-5 (2004).
208. Nuidate, T. et al. Role of Indole Production on Virulence of Vibrio cholerae Using Galleria mellonella Larvae Model. Indian J. Microbiol. 56, 368-74 (2016).
209. Dealler, S. F., Hawkey, P. M. & Millar, M. R. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J. Clin. Microbiol. 26, 2152-6 (1988).
210. Magiatis, P. et al. Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin. J. Invest. Dermatol. 133, 2023-30 (2013).